BlackRock’s Global Cord Blood Corporation CO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-437
Closed -$1.31K 5726
2023
Q1
$1.31K Hold
437
﹤0.01% 5459
2022
Q4
$1.31K Hold
437
﹤0.01% 5624
2022
Q3
$1K Buy
+437
New +$1.07K ﹤0.01% 5785
2021
Q2
Sell
-2,416
Closed -$11K 5659
2021
Q1
$11K Hold
2,416
﹤0.01% 5086
2020
Q4
$9K Sell
2,416
-37,821
-94% -$145K ﹤0.01% 4868
2020
Q3
$142K Sell
40,237
-18,039
-31% -$62.5K ﹤0.01% 4467
2020
Q2
$181K Buy
58,276
+43,707
+300% +$127K ﹤0.01% 4386
2020
Q1
$46K Sell
14,569
-9,687
-40% -$42.4K ﹤0.01% 4493
2019
Q4
$121K Buy
24,256
+16,959
+232% +$81K ﹤0.01% 4411
2019
Q3
$35K Hold
7,297
﹤0.01% 4583
2019
Q2
$42K Hold
7,297
﹤0.01% 4602
2019
Q1
$51K Buy
7,297
+13
+0.2% +$86 ﹤0.01% 4477
2018
Q4
$47K Buy
7,284
+7,044
+2,935% +$45K ﹤0.01% 4488
2018
Q3
$2K Sell
240
-17,590
-99% -$132K ﹤0.01% 4913
2018
Q2
$169K Buy
17,830
+4,429
+33% +$42.4K ﹤0.01% 4350
2018
Q1
$137K Buy
+13,401
New +$137K ﹤0.01% 4283

Other funds holding CO

BlackRock's CO Position: Q2 2023 in Review

BlackRock sold out of Global Cord Blood Corporation (CO) in Q2 2023, closing a stake of 437 shares — an estimated $1.31K sold.

BlackRock first reported a position in CO in Q1 2018 and held it in 16 quarters. The position peaked at $181K in Q2 2020. 6 funds tracked by Wall St. Rank hold CO as of Q2 2023.

  • BlackRock reported no remaining Global Cord Blood Corporation position as of Q2 2023 after selling out during the quarter.
  • BlackRock sold 437 Global Cord Blood Corporation shares in Q2 2023, an estimated $1.31K.
  • BlackRock first reported a position in Global Cord Blood Corporation in Q1 2018 and held it in 16 quarters.
  • BlackRock's Global Cord Blood Corporation position peaked at $181K in Q2 2020.
  • 6 funds tracked by Wall St. Rank held Global Cord Blood Corporation as of Q2 2023.

Based on BlackRock's 13F filing for Q2 2023, filed 11 Aug 2023.